Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Cancer of unknown primary (CUP) remains a major diagnostic hurdle, compromising therapies that depend on accurately identifying tissue of origin. We present TCUP, an ensemble learning framework that combines Contrastive Autoencoders (CAE) and Siamese Neural Networks (SNN) with base classifiers and a meta-learning layer to classify and interpret CUP, adding biological insight through Monte-Carlo ab...
The metabolic heterogeneity of breast cancer represents a significant challenge for the identification of biomarkers and therapeutic targets. To address this problem, we integrated genome-scale metabolic models with machine learning algorithms, aiming to characterize the metabolic phenotypes associated with the disease. There were 90 specific metabolic models generated from clinical and gene expre...
Patient-derived organoids (PDOs) are emerging as advanced 3D ex vivo novel alternative method (NAM) preclinical models, offering significant advantage...
Single-nucleus RNA sequencing (snRNA-seq) generates single cell data from nuclei. It provides valuable compatibility with frozen or difficult-to-disso...
Emerging evidence suggests that the interplay between multiple signaling pathways and the immune microenvironment influences tumorigenesis in cancers ...
Glioblastoma (GBM) is an aggressive brain tumor with limited prognostic biomarkers and therapeutic targets. This study applied an integrated machine l...
Identifying effective neoantigen sequences is essential for enhancing anti-tumor immunity. However, the vast sequence space (>109 possible peptides) a...
Accurate detection of tumors is critical for the success of oncologic surgical intervention. Along with any modality for the localization of tumors, s...
Cancer morbidity disproportionately affects patients in low- and middle-income countries (LMICs), where timely and accurate tumor profiling is often n...
Existing breast cancer risk models inadequately identify individuals at latent risk, particularly among women without known genetic mutations or famil...
All physiological processes fundamentally rely on continuous cellular cross-talk to maintain organization and ensure proper function. Among the variou...
This study introduces a Large Language Model (LLM)-based framework that combines drug combination data with a knowledge graph to predict synergistic o...
The rapid advancement in single-cell, spatial omics, imaging, and genomic technologies requires robust analytical and visualisation platforms capable ...
Reliable sleep stage classification from EEG signals is critical for the development of clinical decision support systems. However, many deep learning...
Analysis of cellular states and signaling trajectories can provide insights into causes of disease. We developed cumulative microscopy, a method to pe...
Histopathological analysis is considered the gold standard for the diagnosis and prognostication of cancer. Recent advances in AI, driven by large-sca...
Human haematopoietic stem and progenitor cells (HSPCs) exhibit heterogeneous lineage output, but the molecular programs underlying clonal fate remain ...
Hepatitis B virus (HBV) infection causes approximately one million deaths annually and remains a major driver of hepatocellular carcinoma. Despite its...
Helicobacter pylori is a significant risk factor for gastric cancer, peptic ulcers, and MALT lymphoma. Rising antibiotic resistance rates complicate t...
Extracellular vesicles (EVs), including exosomes, are emerging as promising carriers of disease-specific biomarkers due to their molecular cargo refle...